DrugPatentWatch Database PreviewSee Plans and Pricing
« Back to Dashboard
Amibegron is an investigational drug.
There have been 4 clinical trials for Amibegron. The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2006.
The most common disease conditions in clinical trials are Depressive Disorder, Major, Depressive Disorder, and Depression. The leading clinical trial sponsors are Sanofi and [disabled in preview].
Recent Clinical Trials for Amibegron
|Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)||Sanofi||Phase 3|
|Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder||Sanofi||Phase 3|
|Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine||Sanofi||Phase 3|